Patent Assignment
Reel/Frame 063348/0762
Release of Security Interest
Recorded: 2023-04-06
Pages: 10
Assignor
MIDCAP FINANCIAL TRUST
Executed: 2023-04-06
Assignees
BIOCRYST PHARMACEUTICALS, INC.
4505 EMPEROR BLVD., DURHAM, NORTH CAROLINA, 27703
MDCP, LLC
4505 EMPEROR BLVD., DURHAM, NORTH CAROLINA, 27703
Covered Properties
(53)
Compositions and Uses of Amidine Derivatives
PCT:
PCT/US2015/046578 ↗
Method for Producing Amidine Derivatives
PCT:
PCT/US2015/046582 ↗
Compositions Comprising a Plasma Kallikrein Inhibitor
PCT:
PCT/US2016/048456 ↗
Inhibitors of Nucleoside Metabolism
Patent:
5,985,848 →
Application:
08/949,388 →
Inhibitors of Nucleoside Metabolism
Patent:
6,066,722 →
Application:
09/172,321 →
Substituted Cyclopentane Compounds Useful as Neuraminidase Inhibitors
Patent:
6,410,594 →
Application:
09/202,351 →
Inhibitors of nucleoside metabolism
Patent:
6,228,847 →
Application:
09/496,741 →
Pyrrolidin-2-One Compounds and Their Use as Neuraminidase Inhibitors
Patent:
6,509,359 →
Application:
09/527,189 →
Substituted Cyclopentane and Cyclopentene Compounds Useful as Neuraminidase Inhibitors
Patent:
6,562,861 →
Application:
09/555,131 →
Novel Compounds Useful in the Complement, Coagulat and Kallikrein Pathways and Method for Their Preparation
Patent:
6,653,340 →
Application:
09/647,154 →
Substituted Pyrrolidine Compounds Useful as Neuraminidase Inhibitors
Patent:
6,518,299 →
Application:
09/692,518 →
Inhibitors of Nucleoside Metabolism
Cyclopentane and Cyclopentene Compounds and Use for Detecting Influenza Virus
Patent:
6,503,745 →
Application:
09/831,140 →
Deazaguanine Analog, Preparation Thereof and Use Thereof
Patent:
6,458,799 →
Application:
09/847,998 →
Process for Preparing 2-Pyrrolidinyl-1H-Pyrrolo[3,2-D]Pyrimidine Inhibitors of Nucleoside Metabolism
Patent:
6,693,193 →
Application:
09/958,219 →
Process for Preparing Substituted Cyclopentane Derivatives and Novel Crystalline Structures Thereof
Inhibiting T-Cell Proliferation
Preparation of Substituted Cyclopentane and Cyclopentene Compounds and Certain Intermediates
Patent:
6,762,316 →
Application:
10/019,217 →
Process for Preparing (-)-(1S, 4R) N-Protected 4-Amino-2-Cyclopentene-1-Carboxylate Esters
Inhibiting T-Cell Proliferation
Patent:
6,656,915 →
Application:
10/088,213 →
Biaryl Compounds as Serine Protease Inhibitors
Patent:
6,699,994 →
Application:
10/127,460 →
Inhibitors of Nucleoside Metabolism
Preparation of Deazaguanine Analog
Patent:
6,780,993 →
Application:
10/367,950 →
Carboxy Pyrrole, Process of Preparing and Use as Precursor
5H-Pyrrolo[3,2-D] Pyrimidine Inhibitors of Nucleoside Phosphorylases and Nucleosidases
Process for Preparing Inhibitors of Nucleoside Metabolism
Biaryl Compounds as Serine Protease Inhibitors
Process for the Preparation of 9-Deazaguanine Derivatives
Inhibitors of Nucleoside Metabolism
Aza Nucleosides, Preparation Thereof and Use as Inhibitors of Rna Viral Polymerases
Process for the Preparation of Substituted Pyrrolidine Derivatives and Intermediates
Nucleosides, Preparation Thereof and Use as Inhibitors of Rna Viral Polymerases
Process for Preparing Inhibitors of Nucleoside Metabolism
Therapeutic Furopyrimidines and Thienopyrimidines
Hepatitis C Therapies
Process for Preparing Inhibitors of Nucleoside Metabolism
Inhibitors of Nucleoside Metabolism
Methods for the Preparation of 9-Deazapurine Derivatives
Acyclic Amine Inhibitors of Nucleoside Phosphorylases and Hydrolases
Hepatitis C Therapies
Fused Pyrimidines as Inhibitors of Nucleoside Phosphorylases and Nucleosidases
Antiviral Nucleoside Analogs
Tetrahydrofuro [3,4-D] Dioxolane Compounds for Use in the Treatment of Viral Infections and Cancer
Antiviral Treatments
Useful Pharmaceutical Salts of 7- [(3R, 4R) - 3 - Hydroxy -4 - Hydroxymethyl - Pyrrolidin -1- Ylmethyl] -3, 5-Dihydro-Pyrrolo [3, 2-D] Pyrimidin -4-One
Methods and Compositions for Inhibition of Polymerase
Application:
13/879,110 →
Publication:
US 2013/0331404
Methods of Treating Hematologic Cancers
Application:
14/190,987 →
Publication:
US 2014/0178372
Antiviral Treatments
Compositions and Methods for Inhibiting Viral Polymerase
Antiviral Azasugar-Containing Nucleosides
Application:
14/441,762 →
Publication:
US 2015/0291596
Methods and Compositions for Inhibition of Polymerase
Anti-Influenza Compositions and Methods
Human Plasma Kallikrein Inhibitors
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Feb 26, 2015
From: INDUSTRIAL RESEARCH LIMITED
To: CALLAGHAN INNOVATION RESEARCH LIMITED
Reel/Frame 035101/0436 →
Assignment of Assignor's Interest
Mar 4, 2015
From: CALLAGHAN INNOVATION RESEARCH LIMITED
To: VICTORIA LINK LIMITED
Reel/Frame 035086/0004 →
Confirmatory License
Jun 15, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035841/0904 →
Assignment of Assignor's Interest
Oct 13, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036851/0385 →
Assignment of Assignor's Interest
Oct 13, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036851/0595 →
Assignment of Assignor's Interest
Oct 14, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036855/0743 →
Assignment of Assignor's Interest
Oct 16, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036878/0001 →
Assignment of Assignor's Interest
Oct 16, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036877/0885 →
Change of Name
Oct 19, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036888/0817 →
Change of Name
Oct 19, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036887/0298 →
Change of Name
Oct 19, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036887/0324 →
Change of Name
Oct 19, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036888/0669 →
Change of Name
Oct 20, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036900/0216 →
Security Interest
Sep 26, 2016
From: BIOCRYST PHARMACEUTICALS, INC.; MDCP, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 039858/0967 →
Merger and Change of Name
Feb 26, 2019
From: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.; ALBERT EINSTEIN COLLEGE OF MEDICINE
To: ALBERT EINSTEIN COLLEGE OF MEDICINE
Reel/Frame 048438/0275 →
Release of Security Interest
Dec 16, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: BIOCRYST PHARMACEUTICALS, INC.; MDCP, LLC
Reel/Frame 054774/0446 →
Security Interest
Dec 17, 2020
From: BIOCRYST PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
Reel/Frame 054800/0634 →
Release of Grant of Security Interest in Patents
Apr 18, 2023
From: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 063362/0550 →